Halozyme Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-03-31 | $28M | 742k | 38.19 |
| 2022-12-31 | $46M | 813k | 56.90 |
| 2022-09-30 | $37M | 931k | 39.54 |
| 2022-06-30 | $43M | 971k | 44.00 |
| 2022-03-31 | $41M | 1.0M | 39.88 |
| 2021-12-31 | $43M | 1.1M | 40.21 |
| 2021-09-30 | $38M | 922k | 40.68 |
| 2021-06-30 | $101M | 2.2M | 45.41 |
| 2021-03-31 | $126M | 3.0M | 41.69 |
| 2020-12-31 | $173M | 4.0M | 42.71 |
| 2020-09-30 | $144M | 5.5M | 26.28 |
| 2020-06-30 | $181M | 6.7M | 26.81 |
| 2020-03-31 | $138M | 7.7M | 17.99 |
| 2019-12-31 | $142M | 8.0M | 17.72 |
| 2019-09-30 | $124M | 8.0M | 15.52 |
| 2019-06-30 | $142M | 8.2M | 17.18 |
| 2018-03-31 | $1.5M | 76k | 19.59 |
| 2017-12-31 | $1.6M | 77k | 20.26 |
| 2017-09-30 | $1.5M | 88k | 17.37 |
| 2017-06-30 | $2.8M | 219k | 12.82 |
| 2017-03-31 | $3.5M | 270k | 12.96 |
| 2016-12-31 | $3.1M | 318k | 9.88 |
| 2016-09-30 | $3.8M | 318k | 12.08 |
| 2016-06-30 | $2.7M | 318k | 8.63 |
| 2016-03-31 | $3.0M | 318k | 9.47 |